Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-01 Sale | 2021-06-03 6:28 pm | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 7,500 | $26.83 | $201,221 | 22,596 (Direct) | View |
| 2021-04-28 Sale | 2021-04-30 5:49 pm | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 10,014 | $25.76 | $257,983 | 30,096 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-17 Option Award | 2022-05-19 4:59 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 25,800 | $0 | 25,800 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 7,500 | $8.39 | 22,596 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 7,500 | $0 | 22,596 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:29 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-04-28 Exercise | 2021-04-30 5:49 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 10,014 | $8.39 | 30,096 (Direct) | View |
| 2021-04-28 Exercise | 2021-04-30 5:49 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 10,014 | $0 | 30,096 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:35 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:08 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Senior VP, Development | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2019-06-05 5:50 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David Sr. VP, Development | 0 | $0 | 65,110 (Direct) | View |